[Treatment of two cases of diffuse retinal pigment epitheliopathy with photodynamic therapy].
METHODS
We present two patients with Diffuse Retinal Pigment Epitheliopathy (DRPE) treated with verteporfin photodynamic therapy (PDT). The first patient was treated with PDT because there was foveal involvement. The second patient received PDT because he had multiple recurrences of DRPE with poor resolution following previous argon-laser photocoagulation. Resolution of the lesions occurred in both cases with improvement in visual acuity. No recurrences have been documented at eleven months of follow-up.


CONCLUSIONS
The outcomes in our patients were satisfactory. We consider PDT is a safe and effective option, but further randomized studies are necessary to confirm this.
Armadá
F
F
Servicio de Oftalmología, Hospital Universitario La Paz, Madrid, España. romeromartinricardo@hotmail.com
Romero
R
R
Ortega
I
I
Fonseca
A
A
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D010857:Pigment Epithelium of Eye; D011166:Porphyrins / Q000627:therapeutic use*; D012164:Retinal Diseases / Q000188:drug therapy*; D000077362:Verteporfin
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin